Lotzová E, Savary C A, Pollack S, Hanna N
Cancer Res. 1986 Oct;46(10):5004-8.
We have investigated the effect of pyrimidinone molecule 2-amino-5-iodo-6-phenyl-4 pyrimidinone (AIPP) on natural killer (NK) cell lytic potential and on the growth of ascitic mammary adenocarcinoma, ACA-755, in B6D2F1 mice. Our studies demonstrated that AIPP was effective in both the prophylaxis and the therapy of this tumor and that the antitumor effect was mediated via induction of NK cell lytic activity. In vitro characterization studies showed that the AIPP-induced cytotoxic cells were not macrophages and exhibited characteristics of NK cells such as morphology of the large granular lymphocytes and sensitivity to asialo GM-1 antibody. Analysis of the mechanism of potentiation of NK cell cytotoxic function by AIPP indicated that the enhancement of cytotoxicity was accomplished by recruitment of NK cell tumor-binding potential (primarily those with large granular lymphocytic morphology) as well as by increased frequency of lytic NK cells. These studies implicate NK cells in the defense against malignant tumors and suggest that regional therapy with AIPP may represent a new therapeutic modality for treatment of cancer.
我们研究了嘧啶酮分子2-氨基-5-碘-6-苯基-4-嘧啶酮(AIPP)对B6D2F1小鼠自然杀伤(NK)细胞裂解潜能以及腹水型乳腺腺癌ACA-755生长的影响。我们的研究表明,AIPP在该肿瘤的预防和治疗中均有效,且其抗肿瘤作用是通过诱导NK细胞裂解活性介导的。体外特性研究表明,AIPP诱导的细胞毒性细胞不是巨噬细胞,而是表现出NK细胞的特征,如大颗粒淋巴细胞的形态以及对去唾液酸GM-1抗体的敏感性。对AIPP增强NK细胞细胞毒性功能机制的分析表明,细胞毒性的增强是通过募集NK细胞肿瘤结合潜能(主要是那些具有大颗粒淋巴细胞形态的细胞)以及增加裂解性NK细胞的频率来实现的。这些研究表明NK细胞参与了对恶性肿瘤的防御,并提示用AIPP进行局部治疗可能代表一种治疗癌症的新方法。